サマリー

がん生物製剤の世界市場 2024-2028
がん生物製剤市場は、2023〜2028年に510億8000万米ドル成長し、予測期間中のCAGRは9.18%で加速すると予測される。当レポートでは、がん生物学的製剤市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、世界的ながん罹患率の上昇、個別化医療の重視によるがん生物学的製剤の需要増加、がん生物学的製剤の大きな治療効果によって牽引されています。
Technavioのがん生物製剤市場は以下のように区分される：
製品別
- モノクローナル抗体
- 細胞・遺伝子治療薬
- ワクチン
- その他
投与経路別
- 注射剤
- 経口
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、発展途上国におけるがん生物学的製剤の未開拓の可能性が、今後数年間のがん生物学的製剤市場の成長を促進する主要な要因の1つであるとしている。また、革新的ながん生物学的製剤の開発のための研究開発の増加と予測バイオマーカーの使用の増加は、市場の大きな需要につながる。
本レポートでは、がん生物学的製剤市場について以下の領域をカバーしています：
- がん生物製剤市場の規模
- がん生物製剤市場の予測
- がん生物製剤市場の産業分析
本レポートでは、癌生物製剤市場の主要ベンダー（Amgen Inc.Ltd.、Cipla Ltd.、Dr. Reddys Laboratories Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、GlaxoSmithKline Plc.、Jazz Pharmaceuticals Plc.、Johnson and Johnson、Lupin Ltd.、Merck KGaA、Novartis AG、Ono Pharmaceutical Co.Ltd.、Viatris Inc.である。また、癌生物製剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cancer-biologics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、合成、要約することにより、市場の詳細な姿を提示しています。業界の主要な影響者を特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global cancer biologics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global cancer biologics market 2018 - 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.3 Route of administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route of administration Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o 6.4 Cell and gene therapy - Market size and forecast 2023-2028
o Exhibit 38: Chart on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
o 6.5 Vaccines - Market size and forecast 2023-2028
o Exhibit 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
o 6.6 Others - Market size and forecast 2023-2028
o Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ billion)
o Exhibit 51: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 52: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 53: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 54: Chart on Comparison by Route of Administration
o Exhibit 55: Data Table on Comparison by Route of Administration
o 7.3 Injectable - Market size and forecast 2023-2028
o Exhibit 56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
o 7.4 Oral - Market size and forecast 2023-2028
o Exhibit 60: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 64: Market opportunity by Route of Administration ($ billion)
o Exhibit 65: Data Table on Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 China - Market size and forecast 2023-2028
o Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 118: AstraZeneca Plc - Overview
o Exhibit 119: AstraZeneca Plc - Product / Service
o Exhibit 120: AstraZeneca Plc - Key news
o Exhibit 121: AstraZeneca Plc - Key offerings
o 12.5 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key news
o Exhibit 125: Bayer AG - Key offerings
o Exhibit 126: Bayer AG - Segment focus
o 12.6 Biocon Ltd.
o Exhibit 127: Biocon Ltd. - Overview
o Exhibit 128: Biocon Ltd. - Business segments
o Exhibit 129: Biocon Ltd. - Key offerings
o Exhibit 130: Biocon Ltd. - Segment focus
o 12.7 Biogen Inc.
o Exhibit 131: Biogen Inc. - Overview
o Exhibit 132: Biogen Inc. - Product / Service
o Exhibit 133: Biogen Inc. - Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 134: Bristol Myers Squibb Co. - Overview
o Exhibit 135: Bristol Myers Squibb Co. - Product / Service
o Exhibit 136: Bristol Myers Squibb Co. - Key news
o Exhibit 137: Bristol Myers Squibb Co. - Key offerings
o 12.9 Celltrion Co. Ltd.
o Exhibit 138: Celltrion Co. Ltd. - Overview
o Exhibit 139: Celltrion Co. Ltd. - Product / Service
o Exhibit 140: Celltrion Co. Ltd. - Key offerings
o 12.10 Cipla Ltd.
o Exhibit 141: Cipla Ltd. - Overview
o Exhibit 142: Cipla Ltd. - Business segments
o Exhibit 143: Cipla Ltd. - Key news
o Exhibit 144: Cipla Ltd. - Key offerings
o Exhibit 145: Cipla Ltd. - Segment focus
o 12.11 Dr Reddys Laboratories Ltd.
o Exhibit 146: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 147: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 148: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 149: Dr Reddys Laboratories Ltd. - Segment focus
o 12.12 Eli Lilly and Co.
o Exhibit 150: Eli Lilly and Co. - Overview
o Exhibit 151: Eli Lilly and Co. - Product / Service
o Exhibit 152: Eli Lilly and Co. - Key news
o Exhibit 153: Eli Lilly and Co. - Key offerings
o 12.13 F. Hoffmann La Roche Ltd.
o Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
o 12.14 Gilead Sciences Inc.
o Exhibit 159: Gilead Sciences Inc. - Overview
o Exhibit 160: Gilead Sciences Inc. - Product / Service
o Exhibit 161: Gilead Sciences Inc. - Key news
o Exhibit 162: Gilead Sciences Inc. - Key offerings
o 12.15 GlaxoSmithKline Plc
o Exhibit 163: GlaxoSmithKline Plc - Overview
o Exhibit 164: GlaxoSmithKline Plc - Business segments
o Exhibit 165: GlaxoSmithKline Plc - Key news
o Exhibit 166: GlaxoSmithKline Plc - Key offerings
o Exhibit 167: GlaxoSmithKline Plc - Segment focus
o 12.16 Jazz Pharmaceuticals Plc
o Exhibit 168: Jazz Pharmaceuticals Plc - Overview
o Exhibit 169: Jazz Pharmaceuticals Plc - Product / Service
o Exhibit 170: Jazz Pharmaceuticals Plc - Key news
o Exhibit 171: Jazz Pharmaceuticals Plc - Key offerings
o 12.17 Merck KGaA
o Exhibit 172: Merck KGaA - Overview
o Exhibit 173: Merck KGaA - Business segments
o Exhibit 174: Merck KGaA - Key news
o Exhibit 175: Merck KGaA - Key offerings
o Exhibit 176: Merck KGaA - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global cancer biologics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Route of administration Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Product ($ billion)
Exhibits51: Data Table on Market opportunity by Product ($ billion)
Exhibits52: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits53: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Route of Administration
Exhibits55: Data Table on Comparison by Route of Administration
Exhibits56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Route of Administration ($ billion)
Exhibits65: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: AstraZeneca Plc - Overview
Exhibits119: AstraZeneca Plc - Product / Service
Exhibits120: AstraZeneca Plc - Key news
Exhibits121: AstraZeneca Plc - Key offerings
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Biocon Ltd. - Overview
Exhibits128: Biocon Ltd. - Business segments
Exhibits129: Biocon Ltd. - Key offerings
Exhibits130: Biocon Ltd. - Segment focus
Exhibits131: Biogen Inc. - Overview
Exhibits132: Biogen Inc. - Product / Service
Exhibits133: Biogen Inc. - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Celltrion Co. Ltd. - Overview
Exhibits139: Celltrion Co. Ltd. - Product / Service
Exhibits140: Celltrion Co. Ltd. - Key offerings
Exhibits141: Cipla Ltd. - Overview
Exhibits142: Cipla Ltd. - Business segments
Exhibits143: Cipla Ltd. - Key news
Exhibits144: Cipla Ltd. - Key offerings
Exhibits145: Cipla Ltd. - Segment focus
Exhibits146: Dr Reddys Laboratories Ltd. - Overview
Exhibits147: Dr Reddys Laboratories Ltd. - Business segments
Exhibits148: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits149: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits150: Eli Lilly and Co. - Overview
Exhibits151: Eli Lilly and Co. - Product / Service
Exhibits152: Eli Lilly and Co. - Key news
Exhibits153: Eli Lilly and Co. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Overview
Exhibits155: F. Hoffmann La Roche Ltd. - Business segments
Exhibits156: F. Hoffmann La Roche Ltd. - Key news
Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits159: Gilead Sciences Inc. - Overview
Exhibits160: Gilead Sciences Inc. - Product / Service
Exhibits161: Gilead Sciences Inc. - Key news
Exhibits162: Gilead Sciences Inc. - Key offerings
Exhibits163: GlaxoSmithKline Plc - Overview
Exhibits164: GlaxoSmithKline Plc - Business segments
Exhibits165: GlaxoSmithKline Plc - Key news
Exhibits166: GlaxoSmithKline Plc - Key offerings
Exhibits167: GlaxoSmithKline Plc - Segment focus
Exhibits168: Jazz Pharmaceuticals Plc - Overview
Exhibits169: Jazz Pharmaceuticals Plc - Product / Service
Exhibits170: Jazz Pharmaceuticals Plc - Key news
Exhibits171: Jazz Pharmaceuticals Plc - Key offerings
Exhibits172: Merck KGaA - Overview
Exhibits173: Merck KGaA - Business segments
Exhibits174: Merck KGaA - Key news
Exhibits175: Merck KGaA - Key offerings
Exhibits176: Merck KGaA - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations